Background: Biliary atresia (BA) is a progressive fibrosing obstructive cholangiopathy
involving both resulting in the intrahepatic and extrahepatic bile ducts. Hepatic …

OBJECTIVE: The prognosis of patients with biliary atresia undergoing Kasai
portoenterostomy is related to the timing of the diagnosis and the indication for the …

Background: Biliary atresia (BA) has unclear etiology, leading to cholestasis and cirrhosis.
Kasai portoenterostomy has been accepted worldwide as the primary treatment for …

Introduction Biliary atresia is a rare liver disease of unknown etiology affecting
approximately 1 in 10,000 children. This disease initially presents as inflammatory …

Objective: To assess the clinical and laboratory parameters, interventions and their
outcomes in children presenting with biliary atresia at a tertiary care hospital. Study Design …

Background Biliary atresia (BA) is the most common surgically correctable liver disorder in
the pediatric age group. If untreated, progressive liver cirrhosis leads to death by the age of …

Objective To study the outcome of Biliary atresia after Kasai's portoenterostomy and clinical
and biochemical factors affecting the outcome. Methods Medical record review of patients of …

Aims: In 1955, Professor Morio Kasai first performed a hepatic portoenterostomy. Since then,
the procedure has changed the lives of children with biliary atresia (BA). We report our initial …

OBJECTIVE: Biliary atresia is the result of a fibrosing destructive inflammatory process
affecting intrahepatic and extrahepatic bile ducts, which lead to cirrhosis and portal …

Purpose We explored the chronologic changes in prognostic factors and clinical outcomes
of Kasai portoenterostomy (KPE) for biliary atresia (BA). Methods Patients undergoing KPE …